MKDWELL Tech (MKDW) Competitors $1.21 +0.09 (+8.04%) (As of 09/18/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends MKDW vs. BYN, NVNI, SLXN, DHAC, VSEE, DMAQ, BENF, ABVE, CTOR, and WENAShould you be buying MKDWELL Tech stock or one of its competitors? The main competitors of MKDWELL Tech include Banyan Acquisition (BYN), Nvni Group (NVNI), Silexion Therapeutics (SLXN), Digital Health Acquisition (DHAC), Vsee Health (VSEE), Deep Medicine Acquisition (DMAQ), Beneficient (BENF), Above Food Ingredients (ABVE), Citius Oncology (CTOR), and ANEW Medical (WENA). These companies are all part of the "holding & other investment offices" industry. MKDWELL Tech vs. Banyan Acquisition Nvni Group Silexion Therapeutics Digital Health Acquisition Vsee Health Deep Medicine Acquisition Beneficient Above Food Ingredients Citius Oncology ANEW Medical MKDWELL Tech (NASDAQ:MKDW) and Banyan Acquisition (NYSE:BYN) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends. Does the media prefer MKDW or BYN? In the previous week, MKDWELL Tech's average media sentiment score of 1.89 beat Banyan Acquisition's score of 0.00 indicating that MKDWELL Tech is being referred to more favorably in the media. Company Overall Sentiment MKDWELL Tech Very Positive Banyan Acquisition Neutral Do insiders & institutionals believe in MKDW or BYN? 13.4% of Banyan Acquisition shares are held by institutional investors. 22.8% of Banyan Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is MKDW or BYN more profitable? Company Net Margins Return on Equity Return on Assets MKDWELL TechN/A N/A N/A Banyan Acquisition N/A N/A N/A Do analysts rate MKDW or BYN? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MKDWELL Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ABanyan Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has better earnings and valuation, MKDW or BYN? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMKDWELL Tech$3.67M1.27N/AN/AN/ABanyan AcquisitionN/AN/AN/AN/AN/A Which has more risk and volatility, MKDW or BYN? MKDWELL Tech has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500. Comparatively, Banyan Acquisition has a beta of 0.03, suggesting that its stock price is 97% less volatile than the S&P 500. Does the MarketBeat Community believe in MKDW or BYN? MKDWELL Tech and Banyan Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformMKDWELL TechN/AN/ABanyan AcquisitionN/AN/A SummaryMKDWELL Tech beats Banyan Acquisition on 3 of the 5 factors compared between the two stocks. Ad GreenlaneThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start with diversification and experience. Founded in 2005, this company serves a diverse and expansive customer base with more than 8,000 retail locations, including licensed cannabis dispensaries, smoke shops, and specialty retailers. Learn more here. Get MKDWELL Tech News Delivered to You Automatically Sign up to receive the latest news and ratings for MKDW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MKDW vs. The Competition Export to ExcelMetricMKDWELL TechHolding Offices IndustryComputer SectorNASDAQ ExchangeMarket Cap$4.65M$414.09M$21.22B$8.25BDividend YieldN/A7.58%2.76%4.08%P/E RatioN/A12.14268.1418.66Price / Sales1.276.97574.6470.57Price / CashN/A67.4130.4231.82Price / BookN/A86.356.774.52Net IncomeN/A$29.54M$636.74M$224.32M7 Day Performance37.94%0.65%1.76%4.99%1 Month PerformanceN/A-1.10%2.11%8.35%1 Year PerformanceN/A-2.82%17.42%11.76% MKDWELL Tech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BYNBanyan Acquisition0 of 5 stars0.00 / 5 stars$1.23-5.4%N/A-89.1%$13.83MN/A0.00N/AGap UpNVNINvni Group3.485 of 5 stars3.49 / 5 stars$1.00-4.8%$5.00+400.0%N/A$10.05MN/A0.00N/AUpcoming EarningsPositive NewsSLXNSilexion Therapeutics0 of 5 stars0.00 / 5 stars$1.01-8.2%N/AN/A$9.87MN/A0.00N/APositive NewsDHACDigital Health Acquisition0 of 5 stars0.00 / 5 stars$1.60flatN/AN/A$5.77MN/A0.002,021VSEEVsee Health0 of 5 stars0.00 / 5 stars$1.60flatN/AN/A$5.77M$6.38M0.00N/AGap UpDMAQDeep Medicine Acquisition0 of 5 stars0.00 / 5 stars$1.26+7.7%N/A-89.2%$5.49MN/A0.0093Gap UpBENFBeneficient1.4179 of 5 stars1.42 / 5 stars$1.27-1.6%N/A-99.4%$5.40MN/A0.0080Gap DownABVEAbove Food Ingredients0 of 5 stars0.00 / 5 stars$0.63flatN/AN/A$5.07MN/A0.00N/APositive NewsCTORCitius Oncology0 of 5 stars0.00 / 5 stars$1.63-0.6%N/AN/A$3.86MN/A0.00N/APositive NewsGap DownWENAANEW Medical0 of 5 stars0.00 / 5 stars$0.73-1.4%N/AN/A$3.77MN/A0.00N/ANews CoveragePositive News Related Companies and Tools Related Companies: Banyan Acquisition Competitors Nvni Group Competitors Silexion Therapeutics Competitors Digital Health Acquisition Competitors Vsee Health Competitors Deep Medicine Acquisition Competitors Beneficient Competitors Above Food Ingredients Competitors Citius Oncology Competitors ANEW Medical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MKDW) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MKDWELL Tech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MKDWELL Tech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.